https://www.selleckchem.com/pr....oducts/e7766-diammon
ue in that it elicits predominantly non-neutralizing antibodies that activate Fc receptors and bind complement, and a glycoprotein D subunit vaccine that elicits neutralizing, but not Fc receptor activating or complement binding responses. Only the single-cycle vaccine provided both active and passive protection against a lethal ocular challenge. These findings greatly expand our understanding of the types of immune responses needed to protect the eye and will inform future prophylactic and therapeutic strategies. Copyrigh
Like
Comment
Share
